SFX by Ex Libris Inc.

Title:	GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice
Source:	Nature Medicine [1078-8956] Kempf, Tibor yr:2011

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Kempf, T.. "Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction." European Heart Journal 28.23 (2007): 2858-2865.
description	2.	Böttner, M. "Expression of a novel member of the TGF-beta superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues." Cell and tissue research 297.1 (1999): 103-10.
description	3.	Rossaint, J. "GDF-15 prevents platelet integrin activation and thrombus formation." Journal of thrombosis and haemostasis 11.2 (2013): 335-344.
description	4.	Noguchi, K. "Down-regulation of interleukin-1alpha-induced matrix metalloproteinase-13 expression via EP1 receptors by prostaglandin E2 in human periodontal ligament cells." Oral microbiology and immunology (2005): 56-9.
description	5.	Takehara N, N. "Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction." Journal of the American College of Cardiology 52.23 (2008): 1858-65.
description	6.	Bouzas-Mosquera, A., Peteiro, J., Vazquez-Rodrigue, Kai C. "Growth-differentiation factor-15 for risk stratification in patients with acute chest pain." European Heart Journal 29.19 (2008): 2327-2327.
description	7.	Zimmers, Teresa A. "Growth differentiation factor-15: induction in liver injury through p53 and tumor necrosis factor-independent mechanisms." The Journal of surgical research 130.1 (2006): 45-51.
description	8.	Griner, Rita E. "Growth differentiation factor 15 stimulates rapamycin-sensitive ovarian cancer cell growth and invasion." Biochemical pharmacology 85.1 (2012): 46-58.
description	9.	Lajer, M. "Plasma Growth Differentiation Factor-15 Independently Predicts All-Cause and Cardiovascular Mortality As Well As Deterioration of Kidney Function in Type 1 Diabetic Patients With Nephropathy." Diabetes care 33.7 (2010): 1567-1567.
description	10.	Vaňhara, P. "Growth/differentiation factor-15: prostate cancer suppressor or promoter?" Prostate Cancer and Prostatic Diseases 15.4 (2012): 320-8.
description	11.	Majak, P. "GDF-15 is increased during early reperfusion following aortic valve replacement." SCJ. Scandinavian cardiovascular journal 46.2 (2011): 99-106.
description	12.	Bottner, M. "Characterization of the rat, mouse, and human genes of growth/differentiation factor-15/macrophage inhibiting cytokine-1 (GDF-15/MIC-1)." Gene 237.1 (1999): 105-111.
description	13.	de Jager, Saskia C A C. "Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis." The Journal of experimental medicine 208.2 (2011): 217-225.
description	14.	Parekkadan, B. "Mesenchymal Stem Cells as Therapeutics." Annual review of biomedical engineering 12.1 (2010): 87-117.
description	15.	Layman, H. "Co-delivery of FGF-2 and G-CSF from gelatin-based hydrogels as angiogenic therapy in a murine critical limb ischemic model." Acta Biomaterialia 5.1 (2009): 230-239.
description	16.	Wan, Y. "Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway." Experimental cell research 315.20 (2009): 3521-3531.
description	17.	Vanderby, Paolo P T. "Intrinsic fibroblast-mediated remodeling of damaged collagenous matrices in vivo." Matrix biology 23.8 (2004): 543-55.
description	18.	Mahrholdt, H. "Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging." Circulation 106.18 (2002): 2322-2327.
description	19.	Foussas, S G G. "The significance of circulating levels of both cardiac troponin I and high-sensitivity C reactive protein for the prediction of intravenous thrombolysis outcome in patients with ST-segment elevation myocardial infarction." Heart 93.8 (2007): 952-6.
description	20.	Shibazaki Sekiya, S. "Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1." Human Molecular Genetics 17.11 (2008): 1505-16.